Why the study?
Does atriopeptin II reduce blood pressure and alter renal function in spontaneously hypertensive rats compared to normotensive rats?
Population
Conscious, spontaneously hypertensive rats and normotensive Wistar-Kyoto rats
Comparison
Atriopeptin II via intravenous bolus injections… vs Normotensive Wistar-Kyoto rats and dose…
Design
Preclinical
Follow-up
90 minutes (for infusion group)
Authors
Loading...
Does not support clinical use; leaves open translation of enhanced hypotensive effects to human hypertension.
Does atriopeptin II reduce blood pressure and alter renal function in spontaneously hypertensive rats compared to normotensive rats?
Atriopeptin II demonstrates potent, dose-dependent blood pressure lowering and natriuretic effects that are more pronounced in spontaneously hypertensive rats.
Gellai et al. (1986) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: